Drug Profile
Amphotericin B - Nanomerics
Alternative Names: METAmphizon; NM-0147Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Nanomerics
- Class Antifungals; Antiprotozoals; Macrolides
- Mechanism of Action Cell membrane permeability enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Leishmaniasis
Most Recent Events
- 28 Aug 2019 No recent reports of development identified for phase-I development in Leishmaniasis in United Kingdom (PO)
- 10 Aug 2016 Chemical structure information added
- 28 Jul 2016 Phase-I clinical trials in Leishmaniasis in United Kingdom (PO)